Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ribrag

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
Toward common response evaluation criteria for solid tumors and lymphomas: RECIL and RECIST?V Ribrag
La Revue De Medecine Interne|January 11, 2005
[Acute tumor lysis syndrome: update on therapy]E Jabbour, V Ribrag
The New England Journal of Medicine|September 29, 2001
Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorderF Suzan, M Ammor, V Ribrag
Hematology/Oncology Clinics of North America|March 20, 2001
Burkitt's acute lymphocytic leukemia (L3ALL) in adultsP Fenaux, J H Bourhis, V Ribrag
European Journal of Cancer (Oxford, England : 1990)|August 19, 2004
Procarbazine in haematology: an old drug with a new life?M Massoud, J P Armand, V Ribrag
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Unusual sites of involvement in non-Hodgkin's lymphoma: Case 2. Isolated meningeal anaplastic large-cell lymphomaS Aloulou, J Bosq, D Vanel, et al.
Presse Medicale (Paris, France : 1983)|February 4, 1995
[Chronic lymphoid leukemia with bone involvement]P Blanche, V Ribrag, F Dreyfus, et al.
Bulletin Du Cancer|January 1, 1992
Infectious complications associated with granulocytopenia during the treatment of poor risk or relapsed germ cell tumorsV Ribrag, J P Droz, J Kattan, et al.
Leukemia|February 1, 1993
Selective increase of alternatively spliced Lck transcripts from the proximal promotor in hematopoietic malignanciesE Rouer, F Dreyfus, J Melle, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 5, 2018
[Radiation therapy planning for Hodgkin lymphoma: Focus on intensity-modulated radiotherapy, gating, protons. Which techniques to best deliver radiation?]A Boros, V Ribrag, É Deutsch, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
Toward common response evaluation criteria for solid tumors and lymphomas: RECIL and RECIST?V Ribrag
La Revue De Medecine Interne|January 11, 2005
[Acute tumor lysis syndrome: update on therapy]E Jabbour, V Ribrag
The New England Journal of Medicine|September 29, 2001
Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorderF Suzan, M Ammor, V Ribrag
Hematology/Oncology Clinics of North America|March 20, 2001
Burkitt's acute lymphocytic leukemia (L3ALL) in adultsP Fenaux, J H Bourhis, V Ribrag
European Journal of Cancer (Oxford, England : 1990)|August 19, 2004
Procarbazine in haematology: an old drug with a new life?M Massoud, J P Armand, V Ribrag
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Unusual sites of involvement in non-Hodgkin's lymphoma: Case 2. Isolated meningeal anaplastic large-cell lymphomaS Aloulou, J Bosq, D Vanel, et al.
Presse Medicale (Paris, France : 1983)|February 4, 1995
[Chronic lymphoid leukemia with bone involvement]P Blanche, V Ribrag, F Dreyfus, et al.
Bulletin Du Cancer|January 1, 1992
Infectious complications associated with granulocytopenia during the treatment of poor risk or relapsed germ cell tumorsV Ribrag, J P Droz, J Kattan, et al.
Leukemia|February 1, 1993
Selective increase of alternatively spliced Lck transcripts from the proximal promotor in hematopoietic malignanciesE Rouer, F Dreyfus, J Melle, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 5, 2018
[Radiation therapy planning for Hodgkin lymphoma: Focus on intensity-modulated radiotherapy, gating, protons. Which techniques to best deliver radiation?]A Boros, V Ribrag, É Deutsch, et al.
Pageof 10